| Application no. and date | 17825829.9 (espacenet) (Federated) (European Patent Register), 20171219 | | Patent/reg. no. and date | DK/EP 3558997, 20210127 | | Publication date | 20191030 | | Priority no. and date | US 201662436619 P, 20161220 | | EP pub. no. and date |
EP 3558997 20191030 | | Effective date | | | Applicant/owner | AstraZeneca AB,
151 85 Södertälje, SE | | Applicant ref. no. | 1575641 | | Inventor | FINLAY, Maurice, Raymond, Verschoyle, AstraZeneca R&D Cambridge
Darwin Building Cambridge Science Park
Milton Road
Cambridge
Cambridgeshire CB4 0FZ, GB,
GOLDBERG, Frederick, Woolf, AstraZeneca R&D Cambridge
Darwin Building Cambridge Science Park
Milton Road
Cambridge
Cambridgeshire CB4 0FZ, GB,
TING, Attilla, Kuan, Tsuei, AstraZeneca R&D Cambridge
Darwin Building Cambridge Science Park
Milton Road
Cambridge
Cambridgeshire CB4 0FZ, GB | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/522 (2006.01) , A61P 35/00 (2006.01) , C07D 473/18 (2006.01) , C07D 519/00 (2006.01) | | Title | AMINOTRIAZOLOPYRIDINFORBINDELSER OG DERES ANVENDELSE TIL BEHANDLING AF CANCER | | Int. application no. | EP2017083625 | | Int. publication no. | WO2018114999 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
